STEAP3 and glioblastoma: In the TCGA GBM cohort, the expression levels of LTF and STEAP3 in IDH wild‐type samples (n = 147) were significantly higher than those with the IDH mutations (n = 11), while no statistical difference in HMOX1 expression existed between the groups (Figure 4A).